Chimeric antigen receptor engineered cells and their clinical application in infectious disease
Abstract Infectious diseases remain a major burden on global public health and socio‐economic stability. Despite that great progress has been made in the development of drugs, the resulting drug resistance remains a major problem. Patients with no response or recurrence need alternative treatment st...
Saved in:
Main Authors: | Chen Qian (Author), Xiao‐Chen Bo (Author), Jia‐Qi Hao (Author), Zeng Wang (Author), Bin Li (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing
by: Qibin Liao, et al.
Published: (2020) -
Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope
by: Alejandrina Hernández-López, et al.
Published: (2021) -
Chimeric antigen receptor T cell therapy for multiple myeloma
by: Kana Hasegawa, et al.
Published: (2019) -
Nanotechnology in Advancing Chimeric Antigen Receptor T Cell Therapy for Cancer Treatment
by: Xuejia Kang, et al.
Published: (2024) -
The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy
by: Yuki Fujiwara, et al.
Published: (2022)